Pimavanserin, also known as ACP-103, is a non-dopaminergic atypical antipsychotic for the treatment of Parkinson's disease psychosis and schizophrenia. Pimavanserin has a unique mechanism of action relative to other antipsychotics, behaving as a selective inverse agonist of the serotonin 5-HT2A receptor, with 40-fold selectivity for this site over the 5-HT2C receptor and no significant affinity or activity at the 5-HT2B receptor or dopamine receptors.
Tags: buy Pimavanserin tartrate | purchase Pimavanserin tartrate | Pimavanserin tartrate cost | order Pimavanserin tartrate | Pimavanserin tartrate chemical structure | Pimavanserin tartrate in vivo | Pimavanserin tartrate in vitro | Pimavanserin tartrate formula | Pimavanserin tartrate molecular weight